Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 USD | +7.93% | -5.35% | +559.22% |
02/05 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05/04 | Elevation Oncology, Inc. Announces Management Changes | CI |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 49 | 17/21/17 |
Tammy Furlong
DFI | Director of Finance/CFO | - | - |
Steven Elms
CHM | Chairman | 60 | 01/19/01 |
Valerie Jansen
CTO | Chief Tech/Sci/R&D Officer | 46 | - |
David Dornan
CTO | Chief Tech/Sci/R&D Officer | 46 | 14/22/14 |
Candice Masse
IRC | Investor Relations Contact | - | - |
Robert Yang
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 18/21/18 |
Timothy Clackson
BRD | Director/Board Member | 58 | 01/20/01 |
Steven Elms
CHM | Chairman | 60 | 01/19/01 |
Darcy Mootz
BRD | Director/Board Member | - | 18/01 |
Joseph Ferra
CEO | Chief Executive Officer | 49 | 17/21/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,691,171 | 51,590,201 ( 94.33 %) | 52,909 ( 0.0967 %) | 94.33 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+559.22% | 18Cr | |
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-0.38% | 2.23TCr | |
-12.15% | 2.21TCr | |
-7.66% | 1.87TCr | |
-36.52% | 1.76TCr | |
-10.09% | 1.69TCr | |
+3.33% | 1.38TCr | |
+36.58% | 1.25TCr |
- Stock Market
- Equities
- ELEV Stock
- Company Elevation Oncology, Inc.